Cobroxin is the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The drug, which was developed by Nutra Pharma\'s wholly-owned drug discovery subsidiary, ReceptoPharm, will be available as an oral spray (NDC47219-102-52) for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel (NDC47219-104-50) for treating pain associated with repetitive stress, arthritis, and joint pain.
Title:
Cobroxin for the Treatment of Chronic Pain
URL:
http://www.Cobroxin.com
Date Updated:
November 5, 2009 05:04 AM
